Stockholm Stock Exchange | Large Cap
Sobi
+29.79%
Latest
+31.06%
3 months
Morgan StanleyPareto SecuritiesNordea MarketsJefferiesRBCHSBCSEBDNB MarketsDeutsche BankKepler CheuvreuxCarnegieRBC Capital MarketsDNBHandelsbanken Capital MarketsMorningstarDanske Bank MarketsDanske BankJefferies InternationalBarclaysHandelsbankenSEB EquitiesABG Sundal Collier

About The Company

Swedish Orphan Biovitrum (Sobi) is a pharmaceutical company with two focus areas: haemophilia and rare diseases. Sobi is a merger of Swedish Orphan and Biovitrum. The company has its premises in Karolinska Institutet Science Park in Solna.
Wikipedia